Sirpa M. Koskela
Tampere, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Early venetoclax dose escalation at minimal residual disease progression may benefit selected acute myeloid leukaemia patients.
Journal: British journal of haematology
Published: March 05, 2026
Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multicentre Trial.
Journal: Basic & clinical pharmacology & toxicology
Published: November 18, 2024
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia.
Journal: Haematologica
Published: June 30, 2022
Diminished coagulation capacity assessed by calibrated automated thrombography during acute Puumala hantavirus infection.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: October 03, 2017
Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant.
Journal: Infectious diseases (London, England)
Published: December 16, 2014
Spleen enlargement is a common finding in acute Puumala hantavirus infection and it does not associate with thrombocytopenia.
Journal: Scandinavian journal of infectious diseases
Published: August 15, 2014
Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: April 23, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026